
Around 195,000 people globally will be treated for this form of lung cancer in 2026

This new option for patients allows for as few as six maintenance injections per year

Newly released study data shows consistent reductions in disease severity

The company has invested $40bn in US R&D and manufacturing in the past seven years

Some patients found the treatment reduced itch and sleep disturbance within just two days

The study found significant reductions of major cardiovascular events in high-risk adults following treatment

The study demonstrated meaningful survival benefits for patients with cutaneous T cell lymphoma

The investment is expected to generate up to 750 new jobs

The phase 3 study included around 2,600 patients

The inflammatory skin condition affects over 26 million people in the US

The inflammatory skin condition occurs in approximately 7.3% of adults in the US

Almost one million new cases of gastric cancer are diagnosed globally every year